1st Quarter - Amendment — GILEAD SCIENCES, INC. for GILEAD SCIENCES INC (2013)

Firm

GILEAD SCIENCES, INC.

Client

GILEAD SCIENCES INC

Income

—

Expenses

$623,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report	Apr 22, 2013	$460,000	Replaced
1st Quarter - Amendment (this page)	Aug 5, 2013	$623,000	Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

HIV/AIDS Technology Transfer and Patent Rights

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

HIV Prevention, Testing and Treatment; HIV/AIDS Funding , including ADAP Funding; Hepatitis B and C Policy; Ryan White Care Act reauthorization

Lobbyist	Covered position, as disclosed
JOSEPH GROGAN	—

Contacted: Commerce, Dept of (DOC); State, Dept of (DOS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.